Bloomberg Shanghai Fosun Pharmaceutical Group Co. scaled back its proposed purchase of control in Indian drugmaker Gland Pharma Ltd. to a level that would allow it to avoid a government review of the biggest Chinese acquisition in India. Fosun Pharma, backed by Chinese billionaire Guo Guangchang, will now buy a 74 percent stake for $1.1 billion, according to a statement. …

How can news organizations avoid the trap that President Trump has laid for them in his attacks on the media as a one-sided “opposition party” that caters to anti-Trump elites and purveys “fake news” to readers and viewers? Part of the answer is simply for journalists to keep doing their jobs, aggressively and fairly. We’re not in the business of …

President Donald Trump has to decide what to do with an American who was fighting for IS, captured by Kurdish forces in Syria and handed over this week to the US military. The best solution is also the simplest: Charge him with material support for terrorism, convict him and lock him up in an appropriate US prison for many, many …